Medical - Healthcare Information Services
Compare Stocks
2 / 10Stock Comparison
NUTX vs CYH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
NUTX vs CYH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Care Facilities |
| Market Cap | $801M | $408M |
| Revenue (TTM) | $880M | $21.48B |
| Net Income (TTM) | $96M | $-88M |
| Gross Margin | 47.5% | 53.7% |
| Operating Margin | 31.4% | -39.8% |
| Forward P/E | 8.7x | 0.8x |
| Total Debt | $351M | $11.58B |
| Cash & Equiv. | $186M | $260M |
NUTX vs CYH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 22 | May 26 | Return |
|---|---|---|---|
| Nutex Health, Inc. (NUTX) | 100 | 9.5 | -90.5% |
| Community Health Sy… (CYH) | 100 | 37.7 | -62.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NUTX vs CYH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NUTX carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 82.4%, EPS growth 7.9%, 3Y rev CAGR 58.6%
- 82.4% revenue growth vs CYH's -1.2%
- 11.0% margin vs CYH's -0.4%
CYH is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 1.60
- -80.3% 10Y total return vs NUTX's -97.8%
- Lower volatility, beta 1.60, current ratio 1.46x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 82.4% revenue growth vs CYH's -1.2% | |
| Value | Lower P/E (0.8x vs 8.7x) | |
| Quality / Margins | 11.0% margin vs CYH's -0.4% | |
| Stability / Safety | Beta 1.60 vs NUTX's 2.01 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +14.6% vs CYH's -11.7% | |
| Efficiency (ROA) | 10.5% ROA vs CYH's -0.7%, ROIC 38.0% vs -70.1% |
NUTX vs CYH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NUTX vs CYH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NUTX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CYH is the larger business by revenue, generating $21.5B annually — 24.4x NUTX's $880M. NUTX is the more profitable business, keeping 11.0% of every revenue dollar as net income compared to CYH's -0.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $880M | $21.5B |
| EBITDAEarnings before interest/tax | $297M | -$7.8B |
| Net IncomeAfter-tax profit | $96M | -$88M |
| Free Cash FlowCash after capex | $270M | -$200M |
| Gross MarginGross profit ÷ Revenue | +47.5% | +53.7% |
| Operating MarginEBIT ÷ Revenue | +31.4% | -39.8% |
| Net MarginNet income ÷ Revenue | +11.0% | -0.4% |
| FCF MarginFCF ÷ Revenue | +30.7% | -0.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.2% | +2.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +154.7% | -45.2% |
Valuation Metrics
CYH leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
At 0.8x trailing earnings, CYH trades at a 94% valuation discount to NUTX's 12.8x P/E.
| Metric | ||
|---|---|---|
| Market CapShares × price | $801M | $408M |
| Enterprise ValueMkt cap + debt − cash | $967M | $11.7B |
| Trailing P/EPrice ÷ TTM EPS | 12.84x | 0.77x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.73x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 3.27x | — |
| Price / SalesMarket cap ÷ Revenue | 0.92x | 0.03x |
| Price / BookPrice ÷ Book value/share | 2.15x | — |
| Price / FCFMarket cap ÷ FCF | 3.26x | 1.96x |
Profitability & Efficiency
NUTX leads this category, winning 7 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), NUTX scores 7/9 vs CYH's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +22.2% | — |
| ROA (TTM)Return on assets | +10.5% | -0.7% |
| ROICReturn on invested capital | +38.0% | -70.1% |
| ROCEReturn on capital employed | +43.2% | -87.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.83x | — |
| Net DebtTotal debt minus cash | $166M | $11.3B |
| Cash & Equiv.Liquid assets | $186M | $260M |
| Total DebtShort + long-term debt | $351M | $11.6B |
| Interest CoverageEBIT ÷ Interest expense | 9.13x | 4.89x |
Total Returns (Dividends Reinvested)
Evenly matched — NUTX and CYH each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CYH five years ago would be worth $1,902 today (with dividends reinvested), compared to $224 for NUTX. Over the past 12 months, NUTX leads with a +14.6% total return vs CYH's -11.7%. The 3-year compound annual growth rate (CAGR) favors NUTX at 20.5% vs CYH's -6.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -9.2% | -6.6% |
| 1-Year ReturnPast 12 months | +14.6% | -11.7% |
| 3-Year ReturnCumulative with dividends | +74.8% | -16.8% |
| 5-Year ReturnCumulative with dividends | -97.8% | -81.0% |
| 10-Year ReturnCumulative with dividends | -97.8% | -80.3% |
| CAGR (3Y)Annualised 3-year return | +20.5% | -6.0% |
Risk & Volatility
Evenly matched — NUTX and CYH each lead in 1 of 2 comparable metrics.
Risk & Volatility
CYH is the less volatile stock with a 1.60 beta — it tends to amplify market swings less than NUTX's 2.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NUTX currently trades 69.7% from its 52-week high vs CYH's 64.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.01x | 1.60x |
| 52-Week HighHighest price in past year | $193.07 | $4.47 |
| 52-Week LowLowest price in past year | $77.21 | $2.38 |
| % of 52W HighCurrent price vs 52-week peak | +69.7% | +64.8% |
| RSI (14)Momentum oscillator 0–100 | 59.7 | 46.4 |
| Avg Volume (50D)Average daily shares traded | 197K | 1.6M |
Analyst Outlook
CYH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates NUTX as "Buy" and CYH as "Hold". Consensus price targets imply 52.3% upside for NUTX (target: $205) vs 1.2% for CYH (target: $3).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $205.00 | $2.93 |
| # AnalystsCovering analysts | 2 | 37 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +0.5% |
NUTX leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CYH leads in 2 (Valuation Metrics, Analyst Outlook). 2 tied.
NUTX vs CYH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is NUTX or CYH a better buy right now?
For growth investors, Nutex Health, Inc.
(NUTX) is the stronger pick with 82. 4% revenue growth year-over-year, versus -1. 2% for Community Health Systems, Inc. (CYH). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate Nutex Health, Inc. (NUTX) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NUTX or CYH?
On trailing P/E, Community Health Systems, Inc.
(CYH) is the cheapest at 0. 8x versus Nutex Health, Inc. at 12. 8x.
03Which is the better long-term investment — NUTX or CYH?
Over the past 5 years, Community Health Systems, Inc.
(CYH) delivered a total return of -81. 0%, compared to -97. 8% for Nutex Health, Inc. (NUTX). Over 10 years, the gap is even starker: CYH returned -80. 3% versus NUTX's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NUTX or CYH?
By beta (market sensitivity over 5 years), Community Health Systems, Inc.
(CYH) is the lower-risk stock at 1. 60β versus Nutex Health, Inc. 's 2. 01β — meaning NUTX is approximately 26% more volatile than CYH relative to the S&P 500.
05Which is growing faster — NUTX or CYH?
By revenue growth (latest reported year), Nutex Health, Inc.
(NUTX) is pulling ahead at 82. 4% versus -1. 2% for Community Health Systems, Inc. (CYH). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to 7. 9% for Nutex Health, Inc.. Over a 3-year CAGR, NUTX leads at 58. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NUTX or CYH?
Nutex Health, Inc.
(NUTX) is the more profitable company, earning 8. 1% net margin versus 4. 1% for Community Health Systems, Inc. — meaning it keeps 8. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUTX leads at 31. 5% versus -79. 4% for CYH. At the gross margin level — before operating expenses — NUTX leads at 50. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NUTX or CYH more undervalued right now?
Analyst consensus price targets imply the most upside for NUTX: 52.
3% to $205. 00.
08Which pays a better dividend — NUTX or CYH?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is NUTX or CYH better for a retirement portfolio?
For long-horizon retirement investors, Community Health Systems, Inc.
(CYH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Nutex Health, Inc. (NUTX) carries a higher beta of 2. 01 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CYH: -80. 3%, NUTX: -97. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NUTX and CYH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NUTX is a small-cap high-growth stock; CYH is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.